FIELD: clinical medicine, dermatology.
SUBSTANCE: method involves application of corticosteroid preparations and cytostatics and additional administration to patient 5% mexidol solution in the dose 2 ml by intramuscular injections, 2 times per 24 h for 10 days. Method results to reducing the total dose of corticosteroid hormones and cytostatics, diminishing adverse effects and intoxication symptoms. Invention can be used in treatment of patients with acantholytic pemphigus.
EFFECT: improved and enhanced treatment method.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING PATIENTS FOR ACANTHOLYTIC BLADDERWORT | 2006 |
|
RU2321395C1 |
| ACANTHOLYTIC PEMPHIGUS TREATMENT METHOD | 2009 |
|
RU2391984C1 |
| METHOD OF TREATING PEMPHIGUS VULGARIS | 2012 |
|
RU2530625C2 |
| METHOD FOR PREDICTING ACANTHOLYTIC PEMPHIGUS RECURRENCE | 2001 |
|
RU2199127C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF AUTOIMMUNE PEMPHIGUS | 2010 |
|
RU2429482C1 |
| METHOD FOR EVALUATING CLINICAL EFFECTIVENESS IN PATIENTS WITH ISOLATED FORM OF ACANTHOLYTIC VESICULAR DISEASE OF ORAL CAVITY | 2018 |
|
RU2688212C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PEMPHIGUS VULGARIS AND PEMPHIGOID | 0 |
|
SU1681183A1 |
| METHOD FOR TREATMENT OF IDIOPATHIC DERMATOMYOSITIS | 1994 |
|
RU2106877C1 |
| METHOD FOR DETECTION OF STEROID RESISTANCE IN PATIENTS WITH TRUE ACANTOLYTIC PEMPHIGUS ON BASIS OF STUDYING SECONDARY MESSENGER SYSTEM | 2011 |
|
RU2473911C1 |
| METHOD OF TREATING PATIENTS WITH MYCOSIS FUNGOIDES | 2010 |
|
RU2455982C1 |
